1,052
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Re: Wang L, Swerdel JN, Weaver J, et al. Incidence rate of hospitalization and mortality in the first year following initial diagnosis of cardiac amyloidosis in the US claims databases. Curr Med Res Opin. 2021;37(8):1275–1281

ORCID Icon
Page 1683 | Received 12 Jan 2022, Accepted 12 May 2022, Published online: 13 Aug 2022

References

  • Wang L, Swerdel JN, Weaver J, et al. Incidence rate of hospitalization and mortality in the first year following initial diagnosis of cardiac amyloidosis in the US claims databases. Curr Med Res Opin. 2021;37(8):1275–1281.
  • Barge-Caballero G, Vázquez-García R, Barge-Caballero E, et al. Light chain and transthyretin cardiac amyloidosis: clinical characteristics, natural history and prognostic factors. Med Clin (Barc). 2021;156(8):369–378.
  • Liu T, Ditzhaus M, Xu J. A resampling-based test for two crossing survival curves. Pharm Stat. 2020;19(4):399–409.
  • Kuitunen I, Ponkilainen VT, Uimonen MM, et al. Testing the proportional hazards assumption in Cox regression and dealing with possible non-proportionality in total joint arthroplasty research: methodological perspectives and review. BMC Musculoskelet Disord. 2021;22(1):489.
  • Dormuth I, Liu T, Xu J, et al. Which test for crossing survival curves? A user’s guideline. BMC Med Res Methodol. 2022;22(1):34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.